Form D — FibroBiologics, Inc.
0001493152-25-025995 · filed 2025-12-03
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $4,000,000
- Total sold
- $4,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- FibroBiologics, Inc.
- CIK
- 1958777
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 455 E. MEDICAL CENTER BLVD, SUITE 300
HOUSTON, TX 77598 - Phone
- 281 671-5150
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Pete O'Heeron · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Stacy Coen · DirectorHouston, TX Find on LinkedIn ↗
-
Robert Hoffman · DirectorHouston, TX Find on LinkedIn ↗
-
Matthew Link · DirectorHouston, TX Find on LinkedIn ↗
-
Victoria Niklas · DirectorHouston, TX Find on LinkedIn ↗
-
Richard C. Cilento · DirectorHouston, TX Find on LinkedIn ↗
-
Jason D. Davis · Executive OfficerHouston, TX Find on LinkedIn ↗
View original on SEC EDGAR.